Anile, Carmelo
 Distribuzione geografica
Continente #
NA - Nord America 6.108
EU - Europa 4.607
AS - Asia 3.577
SA - Sud America 627
Continente sconosciuto - Info sul continente non disponibili 154
AF - Africa 109
OC - Oceania 10
Totale 15.192
Nazione #
US - Stati Uniti d'America 5.928
DE - Germania 1.688
SG - Singapore 1.626
CN - Cina 908
SE - Svezia 572
IT - Italia 532
BR - Brasile 490
UA - Ucraina 402
FR - Francia 328
VN - Vietnam 279
GB - Regno Unito 270
IE - Irlanda 160
IN - India 157
PL - Polonia 157
FI - Finlandia 146
RU - Federazione Russa 135
CA - Canada 118
ID - Indonesia 111
HK - Hong Kong 90
JP - Giappone 82
TR - Turchia 72
BD - Bangladesh 63
BE - Belgio 55
NL - Olanda 48
AR - Argentina 46
IQ - Iraq 41
ES - Italia 33
CI - Costa d'Avorio 32
MX - Messico 29
PK - Pakistan 24
ZA - Sudafrica 22
SA - Arabia Saudita 18
CO - Colombia 17
EC - Ecuador 17
IR - Iran 15
VE - Venezuela 14
CL - Cile 13
EG - Egitto 12
AT - Austria 11
MA - Marocco 10
MY - Malesia 10
PE - Perù 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
PH - Filippine 9
PY - Paraguay 9
UZ - Uzbekistan 9
AL - Albania 8
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
SN - Senegal 8
KE - Kenya 7
RO - Romania 7
TN - Tunisia 7
CH - Svizzera 6
CR - Costa Rica 6
EU - Europa 6
GT - Guatemala 6
IL - Israele 6
JO - Giordania 6
HU - Ungheria 5
RS - Serbia 5
BG - Bulgaria 4
HN - Honduras 4
KR - Corea 4
MD - Moldavia 4
PT - Portogallo 4
TW - Taiwan 4
AZ - Azerbaigian 3
BB - Barbados 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BZ - Belize 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
LT - Lituania 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
Totale 15.030
Città #
Singapore 901
Chandler 758
Ashburn 567
San Jose 457
Ann Arbor 264
Jacksonville 217
San Mateo 171
Beijing 163
New York 159
Dublin 156
Warsaw 139
Dearborn 138
Los Angeles 133
Nanjing 128
Woodbridge 120
Wilmington 105
Ho Chi Minh City 101
Jakarta 96
Lauterbourg 91
Moscow 88
Nürnberg 87
Hong Kong 86
Munich 86
Milan 84
Cattolica 81
Boston 78
Houston 75
Rome 69
Lawrence 66
Hanoi 63
São Paulo 63
Fairfield 60
The Dalles 58
Tokyo 58
Seattle 56
Frankfurt am Main 55
Hefei 55
Brussels 54
Bremen 53
Helsinki 51
Izmir 50
Redwood City 46
Marseille 45
Lancaster 44
Nanchang 44
Toronto 42
Buffalo 41
Kunming 37
Santa Clara 34
Zhengzhou 33
Abidjan 32
Dallas 31
Chicago 30
Mountain View 30
Shanghai 30
Fremont 28
Boardman 25
Hangzhou 25
Atlanta 24
Council Bluffs 24
Detroit 24
Hebei 24
Orem 24
Princeton 24
Augusta 23
Cambridge 22
Jiaxing 22
Norwalk 22
Montreal 21
North York 21
Redmond 19
Tukwila 19
Nuremberg 18
Turku 18
Amsterdam 17
Brooklyn 17
Changsha 17
Paris 17
San Francisco 17
Denver 15
Phoenix 15
Shenyang 15
University Park 15
Düsseldorf 14
Chennai 13
Da Nang 13
Guangzhou 13
Haiphong 13
Johannesburg 13
Leawood 13
Rio de Janeiro 13
Enterprise 12
London 12
Baghdad 11
Belo Horizonte 11
Bexley 11
Kent 11
Memphis 11
Monmouth Junction 11
Newark 11
Totale 7.637
Nome #
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 502
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 499
Intracranial and spinal dissemination of an ACTH secreting pituitary neoplasia. Case report and review of the literature 385
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 319
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 311
Early evaluation of cerebral metabolic rate of glucose (CMRglu) with 18F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement: preliminary experience 290
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 267
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 230
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 228
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 213
ASSESSMENT OF ANGIOGENESIS BY CD105 AND NESTIN EXPRESSION IN PERITUMOR TISSUE OF GLIOBLASTOMA 208
The fate of a macroporous hydroxyapatite cranioplasty four years after implantation: Macroscopical and microscopical findings in a case of recurrent atypical meningioma 208
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 207
Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study 206
Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly 205
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 202
Impact of 4K Ultra-High Definition Endoscope in Pituitary Surgery: Analysis of a Comparative Institutional Case Series 202
Do traumatic brain contusions increase in size after decompressive craniectomy? 199
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 196
Sewing needles in the brain: infanticide attempts or accidental insertion? 196
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 196
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 193
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 193
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 190
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 177
Postoperative infection may influence survival in patients with glioblastoma: simply a myth? 174
Decompressive craniectomy, interhemispheric hygroma and hydrocephalus: A timeline of events? 174
Antiangiogenic therapy for high-grade gliomas: current concepts and limitations 174
Post-traumatic hydrocephalus after decompressive craniectomy: an underestimated risk factor 172
Decompressive craniectomy for elderly patients with traumatic brain injury: it's probably not worth the while 171
Ectopic salivary gland tissue in a Rathke's cleft cyst 164
Cranial repair: how complicated is filling a "hole"? 164
Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study 161
Decompressive craniectomy and hydrocephalus: proposal of a therapeutic flow-chart 161
"Blinding" Empty Sella: Can Lumbar Puncture Be Avoided? 161
Real-time epileptic seizure prediction using AR models and support vector machines. 159
Regional metabolic rate of glucose (CMRglu) evaluation and clinical assessment in idiopathic normal-pressure hydrocephalus (iNPH) patients before and after ventricular shunt placement. A prospective analysis 156
Radioimmunotherapy for high-grade glioma 156
Management of intracranial hypertension following traumatic brain injury: A best clinical practice adoption proposal for intracranial pressure monitoring and decompressive craniectomy: Joint statements by the Traumatic Brain Injury Section of the Italian Society of Neurosurgery (SINch) and the Neuroanesthesia and Neurocritical Care Study Group of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) 156
Decompressive craniectomy for elderly patients with traumatic brain injury: it's probably not worth the while 154
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 154
The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma 151
A rare cause of CSF shunt "failure" in a patient with NPH 151
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 151
Cerebral metabolic rate for glucose of NPH patients increases in shunt-reponders 150
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 150
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 148
Decompressive craniectomy for the treatment of traumatic brain injury: does an age limit exist? 147
Characteristics of ganglion cells in pituitary gangliocytomas 145
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 142
Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis 142
Preoperative embolization of meningiomas with polyvinyl alcohol particles: The benefits are not outweighed by risks. 139
Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme 138
Chronic subdural hematoma in patients aged 80 years and older: A two-centre study 137
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 136
Intratumoral vs systemic administration of meta-tetrahydroxyphenylchlorin for photodynamic therapy of malignant gliomas: assessment of uptake and spatial distribution in C6 rat glioma model. 135
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure 135
In reply 135
Intracranial pressure wave morphological classification: automated analysis and clinical validation 135
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 135
Teaching NeuroImage: Prepontine-suprasellar arachnoid cyst presenting with signs of normal pressure hydrocephalus. 133
Selection of patients with idiopathic normal-pressure hydrocephalus for shunt placement: a single-institution experience 131
Role and Importance of IGF-1 in Traumatic Brain Injuries 131
Esperienza preliminare con endoscopio 4K: Analisi di pro e contro nella chirurgia del basicranio 131
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy 130
Endoscopic treatment of orbital tumors 129
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 129
Usefulness of brain positron emission tomography with different tracers in the evaluation of patients with idiopathic normal pressure hydrocephalous 128
Frataxin participates to the hypoxia-induced response in tumors 124
An experimental study on artificially induced CSF pulse waveform morphological modifications 124
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 119
Preoperative embolization of meningiomas with polyvinyl alcohol particles: The benefits are not outweighed by risks 118
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 117
Bullough's Lesion: An Unexpected Diagnosis After the Resection of a Slowly Growing Osseous-Like Retroauricular Bump—Case Report and Review of the Literature 115
CEREBRAL BLOOD FLOW AUTOREGOLATION DURING INTRACRANIAL HYPERTENSION: A SIMPLE, PURELY HYDRAULIC MECHANISM? 114
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 114
Efficacy of microsurgical sublabial approach (MSA) versus endoscopic endonasal approach (EEA) for the treatment of pituitary adenomas based on radiological and hormonal outcome 112
The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma 109
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma 107
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 107
Parietal intradiploic encephalocele in an adult: a delayed complication of pediatric head injury? 107
Preliminary experience with 4K ultra-high definition endoscope: Analysis of pros and cons in skull base surgery 107
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors 106
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 101
Decompressive craniectomy and hydrocephalus 94
High-grade glioma: elderly patients, older treatments 93
CSF dynamics analysis in patients with post-traumatic ventriculomegaly 90
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 88
Electric fields for the treatment of glioblastoma 80
The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas 77
Decompressive craniectomy for the treatment of traumatic brain injury: Does an age limit exist? A review 76
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma : Final report of a pilot study 76
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 70
The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature 70
Totale 15.192
Categoria #
all - tutte 55.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022868 0 81 21 67 67 52 24 163 55 57 118 163
2022/20232.010 240 293 155 333 135 246 103 161 219 26 51 48
2023/2024854 36 236 23 52 27 125 43 59 10 20 99 124
2024/20251.662 39 68 121 70 173 54 29 81 267 166 319 275
2025/20264.470 618 119 230 435 823 279 843 286 283 300 143 111
2026/2027665 238 427 0 0 0 0 0 0 0 0 0 0
Totale 15.192